Jiannan Xu

430 total citations
22 papers, 184 citations indexed

About

Jiannan Xu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Jiannan Xu has authored 22 papers receiving a total of 184 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Jiannan Xu's work include RNA modifications and cancer (4 papers), Cancer-related molecular mechanisms research (4 papers) and Genetic factors in colorectal cancer (3 papers). Jiannan Xu is often cited by papers focused on RNA modifications and cancer (4 papers), Cancer-related molecular mechanisms research (4 papers) and Genetic factors in colorectal cancer (3 papers). Jiannan Xu collaborates with scholars based in China, Macao and United States. Jiannan Xu's co-authors include Yulong He, Changhua Zhang, Junchang Zhang, Yan Zhang, Weibin Wu, Jian Zhang, Huiguo Chen, Xiaojun Li, Kai Zhang and Yunlong Liu and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and Frontiers in Immunology.

In The Last Decade

Jiannan Xu

19 papers receiving 178 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiannan Xu China 8 64 59 44 25 23 22 184
Junhui Sun China 9 55 0.9× 70 1.2× 34 0.8× 23 0.9× 39 1.7× 28 194
Wan‐Lei Fu China 8 198 3.1× 44 0.7× 34 0.8× 28 1.1× 69 3.0× 15 301
Sichuang Tan China 9 123 1.9× 149 2.5× 44 1.0× 87 3.5× 34 1.5× 20 287
Tarek Abdel‐Aziz United Kingdom 9 21 0.3× 26 0.4× 45 1.0× 33 1.3× 133 5.8× 27 226
Guochun Cao China 8 31 0.5× 61 1.0× 41 0.9× 25 1.0× 43 1.9× 19 148
Fiona Langlands United Kingdom 7 56 0.9× 70 1.2× 91 2.1× 83 3.3× 66 2.9× 11 250
Sunny Haft United States 10 99 1.5× 139 2.4× 56 1.3× 77 3.1× 47 2.0× 14 298
Ming Zhai China 10 37 0.6× 105 1.8× 55 1.3× 19 0.8× 43 1.9× 22 278
Tamara Saurí Spain 9 45 0.7× 65 1.1× 107 2.4× 41 1.6× 49 2.1× 30 226
Amanda M. Dann United States 9 61 1.0× 47 0.8× 133 3.0× 35 1.4× 104 4.5× 16 224

Countries citing papers authored by Jiannan Xu

Since Specialization
Citations

This map shows the geographic impact of Jiannan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiannan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiannan Xu more than expected).

Fields of papers citing papers by Jiannan Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiannan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiannan Xu. The network helps show where Jiannan Xu may publish in the future.

Co-authorship network of co-authors of Jiannan Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Jiannan Xu. A scholar is included among the top collaborators of Jiannan Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiannan Xu. Jiannan Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jin, Hao, et al.. (2025). YTHDC2 manipulates anti-tumoral macrophage polarization and predicts favorable outcomes in triple negative breast cancer. npj Precision Oncology. 9(1). 119–119. 2 indexed citations
2.
Wu, Yonghui, et al.. (2025). The oncomicropeptide IADMP promotes lung cancer progression by stablilized RPS3A expression. Biochemical and Biophysical Research Communications. 796. 152515–152515.
3.
Huang, Yiyao, Junjie Feng, Jiannan Xu, et al.. (2024). Associations of age and sex with characteristics of extracellular vesicles and protein‐enriched fractions of blood plasma. Aging Cell. 24(1). e14356–e14356. 4 indexed citations
4.
Xu, Jiannan, Kai Zhang, Huiguo Chen, et al.. (2024). Squamous cell carcinoma predicts worse prognosis in stage IA (≤ 2 cm) non-small cell lung cancer patients following sublobectomy: a population-based study. Scientific Reports. 14(1). 30998–30998. 1 indexed citations
5.
Xu, Jiannan, et al.. (2024). MEX3A promotes colorectal cancer migration, invasion and EMT via regulating the Wnt/β-catenin signaling pathway. Journal of Cancer Research and Clinical Oncology. 150(6). 319–319. 4 indexed citations
6.
Zheng, Lei, Jiannan Xu, Feng Li, et al.. (2023). Analysis of Mechanical Properties of Air-Ribbed Skeleton Membrane Structure. Applied Sciences. 13(17). 9545–9545. 1 indexed citations
8.
Wu, Weibin, Xiaojun Li, Yonghui Wu, et al.. (2023). A novel localization device for small pulmonary nodules in thoracoscopic wedge resection with adequate margin distance: a retrospective study. Journal of Thoracic Disease. 15(12). 6515–6524. 1 indexed citations
9.
Huang, Weibin, Yuhui Zhang, Haofan Yin, et al.. (2022). Personalized immune subtypes based on machine learning predict response to checkpoint blockade in gastric cancer. Briefings in Bioinformatics. 24(1). 1 indexed citations
10.
Zhang, Xinqian, et al.. (2022). Solution of steering angle based on homogeneous transformation. Proceedings of the Institution of Mechanical Engineers Part D Journal of Automobile Engineering. 236(14). 3124–3134.
11.
Zhang, Junchang, Han Wang, Yuan Cheng, et al.. (2022). ITGAL as a Prognostic Biomarker Correlated With Immune Infiltrates in Gastric Cancer. Frontiers in Cell and Developmental Biology. 10. 808212–808212. 30 indexed citations
12.
Liu, Guangyao, Xing Xiao, Weibin Huang, et al.. (2022). Organoids From Mucinous Appendiceal Adenocarcinomas as High-Fidelity Models for Individual Therapy. Frontiers in Medicine. 9. 829033–829033. 4 indexed citations
13.
Xu, Jiannan, Jianming Liang, Huabin Wang, et al.. (2022). Schlafen family is a prognostic biomarker and corresponds with immune infiltration in gastric cancer. Frontiers in Immunology. 13. 922138–922138. 18 indexed citations
14.
Xu, Jiannan, Songcheng Yin, Huabin Wang, et al.. (2022). Identification of a Two-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival in Diffuse-Type Gastric Cancer. Current Oncology. 30(1). 171–183. 3 indexed citations
16.
Zhang, Lidan, et al.. (2021). Hyperphosphatemia rather than hypophosphatemia indicates a poor prognosis in patients with sepsis. Clinical Biochemistry. 91. 9–15. 20 indexed citations
17.
Xu, Jiannan, Jianlong Jiang, Wenhui Wu, et al.. (2021). Overexpression of ZNF460 predicts worse survival and promotes metastasis through JAK2/STAT3 signaling pathway in patient with colon cancer. Journal of Cancer. 12(11). 3198–3208. 17 indexed citations
19.
Zhang, Kai, Huiguo Chen, Weibin Wu, et al.. (2019). Non-intubated video-assisted thoracoscopic surgery vs. intubated video-assisted thoracoscopic surgery for thoracic disease: a systematic review and meta-analysis of 1,684 cases. Journal of Thoracic Disease. 11(8). 3556–3568. 38 indexed citations
20.
Zhang, Yan, et al.. (2015). Association Between the Gene Polymorphisms of HDAC9 and the Risk of Atherosclerosis and Ischemic Stroke. Pathology & Oncology Research. 22(1). 103–107. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026